呋喃-2-基甲基-[[(2R)-四氢呋喃-2-基]甲基]胺 | 346704-24-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 呋喃-2-基甲基-[[(2R)-四氢呋喃-2-基]甲基]胺
• 中文别名: (2-呋喃甲基)(四氢呋喃-2-基甲基)胺
• 英文名称: Furan-2-ylmethyl-(tetrahydro-furan-2-ylmethyl)-amine
• 英文别名: N-(furan-2-ylmethyl)-1-(oxolan-2-yl)methanamine
• CAS: 346704-24-3
• 化学式: C₁₀H₁₅NO₂
• mdl: MFCD01655154
• 分子量: 181.235
• InChiKey: KWUIUZNTUGNFOF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  34.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2932190090

反应信息

• 作为反应物：
  描述：

  呋喃-2-基甲基-[[(2R)-四氢呋喃-2-基]甲基]胺 在 盐酸 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 3.0h， 生成 3-Oxo-2-(tetrahydro-furan-2-ylmethyl)-2,3-dihydro-1H-isoindole-4-carboxylic acid
  参考文献：
  名称：

  Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy

  摘要：

  The nuclear protein poly(ADP-ribose) polymerase-1 (PARP-1) has a well-established role in the signaling and repair of DNA and is a prominent target in oncology, as testified by the number of candidates in clinical testing that unselectively target both PARP-1 and its closest isoform PARP-2. The goal of our program was to find a PARP-1 selective inhibitor that would potentially mitigate toxicities arising from cross-inhibition of PARP-2. Thus, an HTS campaign on the proprietary Nerviano Medical Sciences (NMS) chemical collection, followed by SAR optimization, allowed us to discover 2-[1-4,4-difluorocyclohexyl)piperidin-4-yl] -6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118, 20by). NMS-P118 proved to be a potent, orally available, and highly selective PARP-1 inhibitor endowed with excellent ADME and pharmacokinetic profiles and high efficacy in vivo both as a single agent and in combination with Temozolomide in MDA-MB-436 and Capan-1 xenograft models, respectively. Cocrystal structures of 20by with both PARP-1 and PARP-2 catalytic domain proteins allowed rationalization of the observed selectivity.

  DOI：

  10.1021/acs.jmedchem.5b00680
• 作为产物：
  描述：

  2-四氢糠胺 、 糠醛 在 sodium tetrahydroborate 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 反应 8.0h， 生成 呋喃-2-基甲基-[[(2R)-四氢呋喃-2-基]甲基]胺
  参考文献：
  名称：

  Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy

  摘要：

  The nuclear protein poly(ADP-ribose) polymerase-1 (PARP-1) has a well-established role in the signaling and repair of DNA and is a prominent target in oncology, as testified by the number of candidates in clinical testing that unselectively target both PARP-1 and its closest isoform PARP-2. The goal of our program was to find a PARP-1 selective inhibitor that would potentially mitigate toxicities arising from cross-inhibition of PARP-2. Thus, an HTS campaign on the proprietary Nerviano Medical Sciences (NMS) chemical collection, followed by SAR optimization, allowed us to discover 2-[1-4,4-difluorocyclohexyl)piperidin-4-yl] -6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118, 20by). NMS-P118 proved to be a potent, orally available, and highly selective PARP-1 inhibitor endowed with excellent ADME and pharmacokinetic profiles and high efficacy in vivo both as a single agent and in combination with Temozolomide in MDA-MB-436 and Capan-1 xenograft models, respectively. Cocrystal structures of 20by with both PARP-1 and PARP-2 catalytic domain proteins allowed rationalization of the observed selectivity.

  DOI：

  10.1021/acs.jmedchem.5b00680

文献信息

• Construction of biomass-based amines <i>via</i> Ir-mediated <i>N</i>-alkylation: kinetic analysis
  作者：Meixiang Liang、Zhongmou Xu、Tianhao Zhou、Limin Chen、Jinzhu Chen

  DOI：10.1039/d3gc04747d

  日期：——

  HCOONa can completely shift N-alkylation to the 5a side by significantly reducing activation energy from 55.3 to 46.8 kJ mol−1 in the 4a-to-5a transfer-hydrogenation stage, which leads to a 15-fold increase in the rate constant for 4a hydrogenation at 140 °C. This research study highlights a kinetic understanding of N-alkylation for the construction of biomass-based amines.

  使用由固定在共价三嗪骨架中的Ir络合物组成的非均相催化剂，通过四氢糠胺( 1a )与糠醇( 2a )的N-烷基化获得基于生物质的仲胺( 5a )。机理研究提出了通过三个连续/可逆步骤的借氢路线：2a脱氢以提供糠醛（3a ），糠醛（ 3a ）转化为亚胺（ 4a ），随后通过第一步中形成的氢化铱对4a进行氢化，最终产生5a。动力学分析揭示了2a至3a脱氢的速率决定步骤以及4a至5a转移氢化中存在可逆平衡。然而，额外加载的HCCOONa氢源可以通过在4a -to -5a转移加氢阶段将活化能从55.3显着降低至46.8 kJ mol -1 ，将N-烷基化完全转移到5a侧，这导致15 140 °C 下4a氢化的速率常数增加一倍。这项研究强调了对N-烷基化用于构建生物质胺的动力学理解。